Stokholm, K.; Thomsen, M.B.; Phan, J.-A.; Møller, L.K.; Bay-Richter, C.; Christiansen, S.H.; Woldbye, D.P.D.; Romero-Ramos, M.; Landau, A.M.
α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease. Biomedicines 2021, 9, 1876.
https://doi.org/10.3390/biomedicines9121876
AMA Style
Stokholm K, Thomsen MB, Phan J-A, Møller LK, Bay-Richter C, Christiansen SH, Woldbye DPD, Romero-Ramos M, Landau AM.
α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease. Biomedicines. 2021; 9(12):1876.
https://doi.org/10.3390/biomedicines9121876
Chicago/Turabian Style
Stokholm, Kathrine, Majken Borup Thomsen, Jenny-Ann Phan, Line K. Møller, Cecilie Bay-Richter, Søren H. Christiansen, David P. D. Woldbye, Marina Romero-Ramos, and Anne M. Landau.
2021. "α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease" Biomedicines 9, no. 12: 1876.
https://doi.org/10.3390/biomedicines9121876
APA Style
Stokholm, K., Thomsen, M. B., Phan, J.-A., Møller, L. K., Bay-Richter, C., Christiansen, S. H., Woldbye, D. P. D., Romero-Ramos, M., & Landau, A. M.
(2021). α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease. Biomedicines, 9(12), 1876.
https://doi.org/10.3390/biomedicines9121876